107 related articles for article (PubMed ID: 29769710)
1. JDP2 overexpression provokes cardiac dysfunction in mice.
Heger J; Bornbaum J; Würfel A; Hill C; Brockmann N; Gáspár R; Pálóczi J; Varga ZV; Sárközy M; Bencsik P; Csont T; Török S; Kojonazarov B; Schermuly RT; Böngler K; Parahuleva M; Ferdinandy P; Schulz R; Euler G
Sci Rep; 2018 May; 8(1):7647. PubMed ID: 29769710
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of AP-1 signaling by JDP2 overexpression protects cardiomyocytes against hypertrophy and apoptosis induction.
Hill C; Würfel A; Heger J; Meyering B; Schlüter KD; Weber M; Ferdinandy P; Aronheim A; Schulz R; Euler G
Cardiovasc Res; 2013 Jul; 99(1):121-8. PubMed ID: 23612584
[TBL] [Abstract][Full Text] [Related]
3. Structural, Pro-Inflammatory and Calcium Handling Remodeling Underlies Spontaneous Onset of Paroxysmal Atrial Fibrillation in JDP2-Overexpressing Mice.
Parahuleva MS; Kockskämper J; Heger J; Grimm W; Scherer A; Bühler S; Kreutz J; Schulz R; Euler G
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265909
[TBL] [Abstract][Full Text] [Related]
4. JDP2 and ATF3 deficiencies dampen maladaptive cardiac remodeling and preserve cardiac function.
Kalfon R; Friedman T; Eliachar S; Shofti R; Haas T; Koren L; Moskovitz JD; Hai T; Aronheim A
PLoS One; 2019; 14(2):e0213081. PubMed ID: 30818334
[TBL] [Abstract][Full Text] [Related]
5. Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.
Van Aelst LN; Voss S; Carai P; Van Leeuwen R; Vanhoutte D; Sanders-van Wijk S; Eurlings L; Swinnen M; Verheyen FK; Verbeken E; Nef H; Troidl C; Cook SA; Brunner-La Rocca HP; Möllmann H; Papageorgiou AP; Heymans S
Circ Res; 2015 Jan; 116(3):425-36. PubMed ID: 25520363
[TBL] [Abstract][Full Text] [Related]
6. JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?
Euler G; Kockskämper J; Schulz R; Parahuleva MS
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923401
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium.
Zhang LX; Du J; Zhao YT; Wang J; Zhang S; Dubielecka PM; Wei L; Zhuang S; Qin G; Chin YE; Zhao TC
J Appl Physiol (1985); 2018 Dec; 125(6):1968-1978. PubMed ID: 30284520
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
[TBL] [Abstract][Full Text] [Related]
9. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
10. Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure.
Hanif W; Alex L; Su Y; Shinde AV; Russo I; Li N; Frangogiannis NG
Cardiovasc Pathol; 2017; 30():27-37. PubMed ID: 28759817
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
[TBL] [Abstract][Full Text] [Related]
12. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
14. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
15. Postnatal ablation of Foxm1 from cardiomyocytes causes late onset cardiac hypertrophy and fibrosis without exacerbating pressure overload-induced cardiac remodeling.
Bolte C; Zhang Y; York A; Kalin TV; Schultz Jel J; Molkentin JD; Kalinichenko VV
PLoS One; 2012; 7(11):e48713. PubMed ID: 23144938
[TBL] [Abstract][Full Text] [Related]
16. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
Louhelainen M; Vahtola E; Forsten H; Merasto S; Kytö V; Finckenberg P; Leskinen H; Kaheinen P; Tikkanen I; Levijoki J; Mervaala E
J Hypertens; 2009 Oct; 27(10):2094-107. PubMed ID: 19730126
[TBL] [Abstract][Full Text] [Related]
17. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling.
Zhao X; Balaji P; Pachon R; Beniamen DM; Vatner DE; Graham RM; Vatner SF
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2451-9. PubMed ID: 26338300
[TBL] [Abstract][Full Text] [Related]
19. Compensatory hypertrophy induced by ventricular cardiomyocyte-specific COX-2 expression in mice.
Streicher JM; Kamei K; Ishikawa TO; Herschman H; Wang Y
J Mol Cell Cardiol; 2010 Jul; 49(1):88-94. PubMed ID: 20170663
[TBL] [Abstract][Full Text] [Related]
20. [Hypertension-induced fibrosis: a balance story].
Azibani F; Fazal L; Chatziantoniou C; Samuel JL; Delcayre C
Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):150-5. PubMed ID: 22681982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
